Company Filing History:
Years Active: 2009-2011
Title: Kumar Emayan: Innovator in Antithrombotic Agents
Introduction
Kumar Emayan is a notable inventor based in Berkeley, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for plasma carboxypeptidase B. With a total of 2 patents, his work has implications for antithrombotic therapies.
Latest Patents
Kumar's latest patents focus on plasma carboxypeptidase B inhibitors. These compounds are described by specific formulas that demonstrate their utility as inhibitors of plasma carboxypeptidase B. The patents also detail pharmaceutical compositions containing these compounds, methods for using them as antithrombotic agents, and processes for synthesizing these compounds.
Career Highlights
Throughout his career, Kumar has worked with prominent companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Bayer Schering Pharma AG. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Kumar has collaborated with several professionals in his field, including Brad Owen Buckman and Imadul Islam. These collaborations have likely enriched his research and development efforts.
Conclusion
Kumar Emayan stands out as an inventor whose work in plasma carboxypeptidase B inhibitors has the potential to advance antithrombotic therapies. His contributions to the pharmaceutical industry reflect his commitment to innovation and improving healthcare outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.